André Barateiro
Marcelo L. M. Pereira
Sabrina Epiphanio
Claudio R. F. Marinho- 1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
- 2Institute of Biosystems and Integrative Sciences, Faculty of Sciences, University of Lisbon, Lisbon, Portugal
- 3Department of Clinical Analysis and Toxicology, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
Annually, many pregnancies occur in areas of Plasmodium spp. transmission, particularly in underdeveloped countries with widespread poverty. Estimations have suggested that several million women are at risk of developing malaria during pregnancy. In particular cases, systemic infection caused by Plasmodium spp. may extend to the placenta, dysregulating local homeostasis and promoting the onset of placental malaria; these processes are often associated with increased maternal and fetal mortality, intrauterine growth restriction, preterm delivery, and reduced birth weight. The endeavor to understand and characterize the mechanisms underlying disease onset and placental pathology face several ethical and logistical obstacles due to explicit difficulties in assessing human gestation and biological material. Consequently, the advent of murine experimental models for the study of malaria during pregnancy has substantially contributed to our understanding of this complex pathology. Herein, we summarize research conducted during recent decades using murine models of malaria during pregnancy and highlight the most relevant findings, as well as discuss similarities to humans and the translational capacity of achieved results.
Malaria in Human Pregnancy
Malaria still represents a serious public health issue for several communities distributed worldwide. Estimations from 2017 have shown that at least 219 million cases occurred in areas of Plasmodium spp. transmission, in which approximately half a million victims died from the disease (World Health Organization, 2018). These estimations encompass pregnant women, who are particularly more susceptible to developing severe clinical manifestations resulting from malaria in pregnancy (MiP) induced by Plasmodium spp. Although outdated, estimations performed by Dellicour et al. (2010) noted 125.2 million pregnancies occurring in malaria-endemic areas. This study came as a follow-up of previous estimations suggesting that 25 million pregnancies occur in areas of P. falciparum transmission alone, distributed across sub-Saharan Africa (Desai et al., 2007). Nevertheless, current epidemiologic knowledge is inaccurate and imprecise and might support outdated and underestimated predictions, hiding a much more alarming reality.
This concerning epidemiological scenario highlights the importance of conducting preventive measures to control MiP, which might drastically evolve to placental malaria (PM), a pathology frequently associated with the occurrence of poor outcomes during pregnancy, such as maternal and fetal mortality, intrauterine growth restriction (IUGR), preterm birth and reduced birth weight (Desai et al., 2007; Umbers et al., 2011; Rogerson et al., 2018). These deleterious consequences affecting both the mother and the growing fetus are reflections of histological and physiological changes occurring within the placenta [recently summarized elsewhere (Sharma and Shukla, 2017)]. One of the key features of P. falciparum PM is the accumulation of P. falciparum-infected erythrocytes (IE) in the placenta (Beeson et al., 2002; Muthusamy et al., 2004). Upregulation of the VAR2CSA protein, a variant of the highly polymorphic adhesion peptide P. falciparum erythrocyte membrane protein 1 (PfEMP1) (Salanti et al., 2003), is responsible for parasite sequestration upon preferential binding to chondroitin sulfate A (CSA), which is abundantly expressed in the placenta (Fried et al., 2006; Muthusamy et al., 2007). Consequently, a severe local inflammatory process is triggered, characterized by the infiltration of monocytes and leukocytes in the placenta and eventual inflammation in response to parasite accumulation (Ismail et al., 2000; Parekh et al., 2010; Lucchi et al., 2011; Souza et al., 2013). This process has been frequently associated with placental histological alterations during MiP, such as dysregulation of placental architecture, formation of syncytial knots, fibrin deposition, necrosis, and placental barrier thickening (Walter et al., 1982; Ismail et al., 2000; Souza et al., 2013), and has been reported to occur during IUGR and preterm delivery, as well as in cases of reduced birth weight (Moormann et al., 1999; Menendez et al., 2000; Rogerson et al., 2003; Umbers et al., 2011).
Although we have obtained substantial knowledge in the field, studies on the epidemiology and pathology of MiP are frequently challenging due to related ethical and logistic difficulties. Long gestational periods, uncontrollable experimental planning, difficult access to biological and placental samples, and critical constraints associated with human experiments represent significant barriers that slow research progress and the understanding of this severe and complex disease. Therefore, alternatives have emerged with the advent of murine models to study MiP that have brought fundamental knowledge to the field. Herein, we have compiled research conducted for the past four decades using experimental rodent models, highlighting the most relevant findings, similarities to humans and, consequently, the translational capacity of achieved results.
Human and Murine Gestation: Comparison and Translational Challenges for the Study of MiP
Comparative Gestation Development
In parallel with some other features, gestation length and development are somewhat different between human and murine mammals. Human gestation lasts for approximately 38 weeks (three trimesters) in contrast to rodents, in which gestation takes place over a 3-week period (Murray et al., 2010). In addition, there are also slight differences between species regarding the implantation period. Murine implantation takes place between the fourth and fifth days of gestation, somewhat sooner than in humans, in which this phenomenon occurs between the fifth and sixth days (Rossant and Tam, 2017). After implantation, gestation will progress toward a shift in fetal nutritional means. During early gestation in both humans and rodents, the growing fetus will survive through means of histiotrophic nutrition, in which nutrients are acquired by the uptake of substances secreted from the uterine glands present in the endometrium (Burton et al., 2002; Georgiades et al., 2002). However, the nutritional strategy changes around mid-gestation when the maternal blood supply to the placenta is completely established. Accordingly, the nutrient and gas exchanges between the mother and the fetus become functional, marking the onset of placental hemotrophic nutrition (Burton et al., 2001; Georgiades et al., 2002). In humans, this phenomenon occurs between the end of the first and the beginning of the second trimester, while in mice and rats, the same scenario occurs specifically at mid-gestation (between the twelfth and thirteenth days) (Georgiades et al., 2002). This shift in nutritional strategy occurs with the onset of organogenesis and fetal development, after which growth will continue until gestational term is reached.
Comparative Placental Function, Structure, and Histology
Human and murine placentas have a considerable degree of similarity and are nearly identical from physiological and functional perspectives (Rossant and Cross, 2001; Georgiades et al., 2002). In both mammalian species, this transient organ ensures nutrient and gas exchange between the mother and the growing fetus (Lager and Powell, 2012), maintains tolerance to the maternal immune system (Kanellopoulos-Langevin et al., 2003), and works as a physical and immunological barrier against endogenous pathogens (Robbins and Bakardjiev, 2012).
The placentas in both species are discoid organs in which maternal blood coming from the endometrium circulates and is in direct contact with trophoblasts, the fetal-derived cells responsible for regulating most placental physiological functions. In both species, the placenta can be structurally divided into three main areas: (1) an outer layer, consisting of uterine decidual cells and maternal blood vessels; (2) a middle layer, considered the implantation site where the placenta attaches to the uterus; and (3) an inner layer, in which the maternal blood interacts with trophoblasts to promote vital metabolic exchanges [reviewed elsewhere (Georgiades et al., 2002)]. Accordingly, the outer area can be mainly described as being composed by the myometrium and decidua basalis, which are extensively infiltrated by maternal arteries. This area is partially invaded by fetal-derived trophoblasts during the implantation process, which is considerably similar between both mammalian species. Moving toward the inner area of the human placenta, it is possible to distinguish a structural layer with no counterpart in the murine placenta known as the basal plate. This implantation site contains several distinct trophoblast subpopulations, such as extravillous (EVT) and cytotrophoblast (CT) cells. Nevertheless, an analogous area defined as the junctional zone occurs in murine animals, which is populated by specific types of cells such as trophoblast giant cells (TGC) and spongiotrophoblasts (SPG). Inside the placenta, more pronounced differences are observed regarding morphology and structure. The central area, which is commonly referred to as the human fetal placenta, is constituted by villi in an extremely ramified tree-like structure, which increases the contact surface with the maternal blood freely circulating within the intervillous space (IVS) (Figure 1A). On the other hand, a similar structure known as the labyrinth develops in mice and rats (Figures 2A,C). This impacts maternal blood circulation inside the placenta, where blood stays confined to the tortuous and sinusoidal channels (Rossant and Cross, 2001). Additionally, the surface area contacting the maternal blood is somewhat distinguished between humans and rodents from both cytological and structural perspectives. In the human placenta, maternal blood is separated from fetal capillaries by a single layer of syncytiotrophoblasts (ST), beyond which CT cells are present together with the basal lamina and fetal endothelium (schematically represented in Figure 3). According to these characteristics, the human placenta is classified as hemomonochorial (Takata et al., 1997; Georgiades et al., 2002). In opposition, three layers compose the murine labyrinthine wall: one composed of mononuclear trophoblasts dispersed throughout the surface contacting maternal blood and two ST layers definitively separating the maternal and fetal compartments (illustrated in Figure 3). Accordingly, murine placentas are classified as hemotrichorial (Takata et al., 1997).
Figure 1. Histologic events associated with placental pathology during human malaria in pregnancy. Placental histologic sections of non-infected (A) and P. falciparum-infected (B–F) women stained with Hematoxylin-Eosin. (A) Healthy human placenta without tissue damage and normal architecture in which intervillous spaces (IVS), usually bathed in maternal blood are in contact with placental villi (V), feeding the growing fetus through the fetal vessels (FV). (B) P. falciparum-infected placentas often characterized by extensive necrotic areas (Ne) and tissue disorganization. (C,D) Mononuclear cells infiltrate (arrow) is frequently patent due to the accumulation of parasitized erythrocytes (arrowhead). (E) Massive sequestration of P. falciparum-infected erythrocytes in the placenta is accompanied by (F) the accumulation of hemozoin in the IVS, which can be detected by polarized light microscopy. Scale bars represent (A,B,E,F) 100 μm, (C) 5 μm, and (D) 15 μm. Microscopy pictures were taken by Rodrigo Medeiros de Souza.
Figure 2. Histologic events associated with placental pathology during murine malaria in pregnancy. Placental histology of non-infected (A,C) and P. berghei-infected (B,C,E,F) mice stained with Hematoxylin-Eosin. (A) Healthy placenta with normal histologic structure characterized by normal distribution of layer-specific cell such decidual cells (DC), trophoblastic cells (Cy), and labyrinthic cells (La), having (C) a normal labyrinth organization. (B) Fibrinoid necrosis (Ne) is depicted in section of P. berghei-infected placentas with (D) massive tissue disorganization and trophoblast membrane thickening. (E) Mononuclear cell infiltrate is visible (arrow), which occurs in response to (D) parasite accumulation (arrow) and (F) hemozoin deposition observed using polarized light microscopy. Scale bars represent (A,B) 100 μm, (C–E) 15 μm, and (F) 30 μm. Figure was modified from Neres et al. (2008) and Marinho et al. (2009) upon permission granted on behalf of journal’s editorial board.
Figure 3. Schematic representation of possible histologic events in human and murine placentas during malaria in pregnancy. Human and murine fetuses are represented with corresponding placentas. Magnification of transversal slices of each placental core illustrate histologic architecture, which widely differs between human placental villi and murine labyrinthine structure. During malaria in pregnancy, both human and murine placentas experience histopathologic manifestations that impair local homeostasis and lead to poor pregnancy outcomes. A comparison between both infected placentas and their non-infected counterparts is depicted. The presence of monocyte infiltrate is visible, which occurs in response to parasite and hemozoin accumulation. Histologic modifications such as fibrin deposition and syncytial knots occur due to the onset of severe local inflammation. Legend of picture components is vertically displayed beside the scheme.
Nevertheless, the structural divergences of human and murine placentas have occurred in parallel with an extensive variety of resident cell populations that are independent of their analogs but not similar in development and characteristics and are equally responsible for the same physiological and functional processes in human, mouse and rat placentas (Figure 3).
Using Murine Models to Study Malaria in Human Pregnancy
It is required that a suitable experimental model includes a group of features that lead to valid and translatable findings. As such, it is pivotal that rodent physiology and genetics, as well as pathologic manifestations during disease, resemble those in humans to a certain extent, ultimately validating them as models for human research (Justice and Dhillon, 2016). Accordingly, after several models were reviewed, mice and rats were validated by Desowitz as suitable to study MiP (Duffy and Fried, 2001) under the assumption that physiological and pathological similarities observed between rodents and humans were sufficient to consider them appropriate to study this disease. Shared placental characteristics, such as hemochorial and discoid structure (Georgiades et al., 2002; Wildman et al., 2006), hemotrophic nutrition (Burton et al., 2001; Georgiades et al., 2002) and analogous placental cell populations (Rossant and Cross, 2001; Georgiades et al., 2002), encourage their usage as models of MiP. These similarities are supported by molecular phylogenetic analysis, which clusters both rodents and humans into the same evolutionary clade (Wildman et al., 2006). The molecular similarities can be extended to immunity, an important aspect to consider when studying a disease in which poor outcomes are predominantly dependent on the host’s immune response to malaria (Moormann et al., 1999; Rogerson et al., 2003). Hence, despite controversial discussion, it was shown that patterns of gene expression and biological pathways altered in mouse models of inflammatory diseases were significantly correlated with those from corresponding human conditions (e.g., sepsis) (Takao and Miyakawa, 2015), further supporting the usage of these animals for studying inflammatory diseases such as MiP. Together with the features mentioned above, the short gestational period, capacity for frequent and successive pregnancies, as well as large litter sizes, allow the rapid gathering of a considerable number of biological samples, which makes the rodents a powerful model for studying any pregnancy-related disease.
In addition to host characteristics, parasite intrinsic features are essential to validate experimental models of MiP. Above all, the most relevant features to consider should be the similarities between human and murine parasites cytoadhesion mechanisms. It is well known that the pathogenesis mechanisms involved in severe malaria induced by P. falciparum are associated with tissue- and organ-specific sequestration of IE (Schofield and Grau, 2005). More specifically, P. falciparum MiP may lead to severe PM as a result of IE sequestration in the placenta, which is mediated by the PfEMP1 variant VAR2CSA (which binds to placental CSA). The wide range of PfEMP1 variants known to be encoded by 50–60 var genes (Kraemer and Smith, 2006) have no known homologs in murine parasites (Hall et al., 2005). In fact, only some genetic signatures are similar between the murine and human Plasmodium species that encode alternate variable surface antigens (VSA), which were grouped in the multigenic pir superfamily (Plasmodium interspersed repeats) (Janssen et al., 2004; Hall et al., 2005). Nevertheless, murine parasite strains such as P. berghei have been shown to accumulate in specific tissues such as brain, fat, lung and spleen in a CD36-dependent and independent manner, which is also a well conserved pathogenesis mechanisms of severe malaria induced by P. falciparum (Franke-Fayard et al., 2010). In the same extent, the expression of alternate VSA and the binding capacity to placental CSA observed in murine parasites support the conclusions regarding the similarities between the pathogenesis mechanisms involved in murine and human disease (Hall et al., 2005; Neres et al., 2008; Marinho et al., 2009; Hviid et al., 2010). Distinct mechanisms of pathogenesis might also be directly linked with the biology of the parasites. As such, it is advisable to consider that the usage of murine parasites needs to be adjusted with caution since specific strains might better mimic the distinct diseases associated with the unrelated biology of human parasites (e. g. P. falciparum or P. vivax). Accordingly, disease severity in mice tends to be higher in P. berghei ANKA causing lethal anemia and cerebral malaria in C57BL/6 for instance (resembling P. falciparum in humans); however, it has a tropism for reticulocytes (similar to P. vivax). Differently, P. chabaudi invades mature erythrocytes and is responsible for a less severe pathology shown by the resistance to infection observed in BALB/c and C57BL/6 mice. In the same extent, different parasites might also have different tendencies to accumulation in specific tissues, being better used to study specific diseases and host-pathogen interactions (reviewed in Lamb et al., 2006).
Despite the aforementioned host and parasite characteristics, one must carefully translate findings obtained in murine models to humans, especially regarding preclinical observations, due to the observed differences between both mammals. Nevertheless, the following sections will depict some of the current knowledge acquired using murine models of MiP (research details for each model are presented in Table 1) during the past decades while describing the parallel characteristics existing between humans and rodents in regard to poor pregnancy outcomes and MiP placental pathology (summarized list in Table 2).
Table 1. Summary of the principal findings and observations done using murine models of malaria in pregnancy.
Table 2. Compilation of references mentioning the main pathologic manifestations of malaria in pregnancy observed in humans and murine models.
Contribution of Murine Models to the Study of MiP
Understanding Recrudescence Using Murine Models of MiP
Currently, we have been facing the emerging problem of drug resistance acquisition observed in P. falciparum infections, the outcome of which might be the occurrence of recrudescence (without a new infection episode) as a consequence of subcurative therapy (Cattamanchi et al., 2003; Berrevoets et al., 2013). In addition to treatment incapacity to clear circulating parasites, the immune depression observed in specific situations, such as during pregnancy, might elicit the emergence of recrudescent parasites that are either dormant or at submicroscopic levels (Giobbia et al., 2005; Mayor et al., 2009; Laochan et al., 2015; Al Hammadi et al., 2017; Malvy et al., 2018). In this context, some of the first available studies using murine models of MiP appeared during the early 1980s, when van Zon and Eling first described recrudescence in pregnant mice infected with P. berghei (van Zon and Eling, 1980; van Zon et al., 1982). Females of different mouse strains (Swiss, C3H/StZ, BALB/c, and B10LP) challenged with P. berghei K173 were treated with chloroquine and sulfadiazine to decrease parasitemia and promote the acquisition of immunity before mating. Afterward, pregnancy was shown to induce recrudescence, which was clearly shown to be strain- and gravidity-dependent (van Zon and Eling, 1980) and linked to preterm delivery and maternal mortality (van Zon et al., 1982). Consequently, the pioneering results enabled the authors to draw brief conclusions on similarities observed between human and murine recrudescence by determining that the phenomenon could be associated with (1) the drugs’ incapacity to completely clear the parasite in a previous malaria episode and (2) the particular immune status associated with pregnancy, recapitulating the features of recrudescence in human MiP (Giobbia et al., 2005; Al Hammadi et al., 2017; Malvy et al., 2018). Pregnancy-associated immune modulation was then shown to be linked to increased production of corticoids during murine gestation, thereby facilitating the onset of recrudescence (van Zon et al., 1982, 1985). Notwithstanding the relevance of van Zon and coworkers’ findings, parasite reappearance in maternal circulation was often ensured by experimental reinfection, raising questions about the translational reliability of murine recrudescence results obtained in these models (van Zon and Eling, 1980; van Zon et al., 1982).
Despite the promising advances made during that period, recrudescence in murine models was poorly addressed until the last decade. Only in 2009, two studies have addressed questions about the topic (Marinho et al., 2009; Megnekou et al., 2009). By reevaluating the pioneering experimental model implemented by van Zon and coworkers, the team of Megnekou addressed the production of specific anti-VSA antibodies in pregnant BALB/c mice immunized against P. berghei K173. Although previously immunized, protection was lost during pregnancy due to the recrudescence of parasites expressing specific VSA. Consequently, protection was shown to be gravidity-dependent since the less susceptible multiparous mice have raised antibodies against parasite-specific VSA during their previous pregnancies (Megnekou et al., 2009). However, some parasite reappearances were once again ensured by experimental infections, raising the same translational limitations discussed above. During that same year, a study from Marinho et al. (2009) established a model to study recrudescence in BALB/c mice, however, without recurring to mid-gestation reinfection. Accordingly, non-pregnant mice were infected with P. berghei ANKA and administered a subcurative treatment to clear apparent parasitemia. Mice were then mated approximately 1 month later and analyzed for recrudescence, which occurred in up to 58% of pregnant mice from gestational day (G)12 onward (Marinho et al., 2009). Maternal mortality and parasitemia were shown to be increased in primigravidae, which diminished with increased gravidity, supporting the observations of Megnekou et al. (2009) regarding acquired immunity in subsequent pregnancies.
Nevertheless, both recrudescent and newly inoculated parasites constitute a risk for highly susceptible pregnant women (Laochan et al., 2015). Accordingly, a recent study has shown that P. chabaudi CB sporozoites are capable of inducing recrudescence in pregnant C57BL/6 mice, being more closely related to the human parasite life cycle. However, poor pregnancy outcomes, such as maternal mortality and reduced birth weight, were likely to occur upon heterologous reinfection with P. chabaudi AS rather than in the cases of recrudescence. Preacquired immunity against the recrudescent parasite might justify why only reinfection with heterologous parasite lead to poor pregnancy outcomes. Nonetheless, exposure to heterologous P. chabaudi AS ensures newborn protection against postnatal infection, reliably resembling the outcomes of human MiP (Sharma et al., 2016).
Although observed in murine MiP, some studies have reported no recrudescence in protocols of treatment and immunization used in mice to control infection before pregnancy (Pathak et al., 1990; Pavia and Niederbuhl, 1991). Explanations might rely on the (1) drug efficiency to clear circulating parasite, (2) usage of less virulent strains (e.g., P. berghei NICD and P. yoelii 17X), or (3) less susceptible mice strains (e.g., Swiss Albino VRC). Nonetheless, despite some controversial experimental settings, findings associated with the aforementioned murine models have revealed some hidden biological features associated with malaria recrudescence during pregnancy that otherwise would be impossible to address.
Understanding Poor Pregnancy Outcomes Using Murine Models of MiP
A multitude of outcomes can occur as a result of developing MiP. When considering the areas of P. falciparum frequent and stable transmission, pregnancy-associated consequences might depend on several aspects such as infection trimester, gravidity and maternal health status that ultimately dictate the onset of maternal anemia, fetal and maternal mortality, abortion, and reduced birth weight as consequences of IUGR and/or preterm delivery (Desai et al., 2007; Umbers et al., 2011; Rogerson et al., 2018). Outcomes in human pregnancy are accessible for study; however, in addition to ethical constraints, illogical and incorrect correlations might be drawn from imprecise information given by patients enrolling in these prospective studies, such as imprecise time of infection or clinical status. Fittingly, murine models provided the opportunity to investigate MiP outcomes in a controlled experimental setting.
Maternal Anemia
Maternal anemia that develops during MiP is considered a significant risk factor for poor pregnancy outcomes and is closely associated with increased parasite burden and reduced birth weight (Rogerson et al., 2003). Accordingly, several distinct experimental murine models accurately recapitulate anemia observed during human MiP. Similarly, P. chabaudi AS infection potentiates the onset of anemia (reduced hematocrit percentage) in pregnant C57BL/6 mice. Anemia was therefore linked to a rapid increase in parasitemia, which peaks abruptly in pregnant mice (Poovassery and Moore, 2006; Poovassery et al., 2009; Avery et al., 2012; Sarr et al., 2012). This phenomenon was also shown to occur in different murine strains, such as BALB/c mice (Hioki et al., 1990) and Wistar rats (Desowitz et al., 1989), infected with P. berghei NK65 and NYU-2, respectively, in which hemoglobin and hematocrit decreased as a result of increased parasitemia. Reproducibility of anemia is expected among different experimental models since hemolysis constitutes an intrinsic step in the Plasmodium spp. life cycle in both rodents and humans. Nevertheless, this critical parameter has been poorly investigated in murine malaria, in which its relationship with infection timing, gravidity, and pregnancy outcomes were never addressed as in humans (Brabin et al., 2001; Rogerson et al., 2003).
Maternal Mortality
Maternal mortality seems to be a less frequent outcome in pregnancies complicated by malaria (Menéndez et al., 2008; Rogerson et al., 2018). Maternal death associated with Plasmodium spp. infection tends to occur more frequently in areas of low malaria transmission due to the reduced level of premunition (Nosten et al., 2004). Nevertheless, pregnant women with malaria who live in endemic areas are also prone to die due to severe anemia (Brabin et al., 2001; Shulman et al., 2002). Likewise, both pregnant mice and rats infected with murine Plasmodium spp. strains were shown to die during gestation, which was dependent on the parasite strain, infection timing, and host intrinsic characteristics. Regarding parasite strains, it was demonstrated that P. berghei (van Zon and Eling, 1980; Oduola et al., 1982; van Zon et al., 1982; Vinayak et al., 1986; Desowitz et al., 1989; Hioki et al., 1990; Pathak et al., 1990; Neres et al., 2008; Marinho et al., 2009; Megnekou et al., 2009; Rodrigues-Duarte et al., 2012; Sharma and Shukla, 2014), P. yoelii (Pavia and Niederbuhl, 1991), and P. chabaudi (Poovassery and Moore, 2006, 2009; Poovassery et al., 2009; Sarr et al., 2012; Sharma et al., 2016) induce maternal death in a considerable variety of experimental settings. However, only one study has directly compared this outcome induced by different parasites, clearly showing increased mortality rates in pregnant C57BL/6 mice infected with P. berghei NK65 compared to K173 and ANKAΔpm4 strains (Rodrigues-Duarte et al., 2012). One must consider that mortality rates also depend on host susceptibility to infection since, for instance, pregnant A/J mice experience a higher risk of mortality than C57BL/6 mice when infected with P. chabaudi AS (Sarr et al., 2012). These findings support the notion that maternal survival is dependent on both parasite and host intrinsic features. Similarly, mortality was shown to increase in pregnant C57BL/6 and BALB/c mice infected with P. chabaudi (Poovassery and Moore, 2006; Poovassery et al., 2009) or P. berghei (Neres et al., 2008; Rodrigues-Duarte et al., 2012), respectively, when compared to their non-pregnant counterparts. This is a well-known phenomenon that also occurs in humans who are primarily in areas of unstable malaria transmission (Luxemburger et al., 1997; Nosten et al., 2004). Infection timing was also shown to be linked to maternal mortality, which primarily increases in cases of early gestation infection. This was demonstrated to occur in Wistar rats (Desowitz et al., 1989), as well as in Swiss Albino, A/J, ICR, and BALB/c mice (Oduola et al., 1982; Vinayak et al., 1986; Hioki et al., 1990) infected with P. berghei. However, mid-gestation infection was shown to lead to increased survival with a higher number of animals achieving parturition. Interestingly, it is unclear whether this occurs in humans and if first trimester infections lead to increased maternal mortality rates (Desai et al., 2007; Rogerson et al., 2018). Nevertheless, regardless of the infection trimester, mortality is highly dependent on gravidity and is more prevalent in primigravidae than in multiparous women (Menéndez et al., 2008). Equally, mice tend to experience the same effect, which is likely to be dependent on immunity acquired during previous gestations (van Zon and Eling, 1980; Marinho et al., 2009). Accordingly, immunity seems to be pivotal in reduced murine mortality, as ICR mice immunized with attenuated P. yoelii before pregnancy had improved survival rates when challenged with the lethal P. yoelii 17X strain (Pavia and Niederbuhl, 1991). Although a direct causality has never been proved, increased mortality observed in murine models of MiP seem to be associated with the development of systemic infection measured by increased peripheral parasitemia that correlates with decreased body weight and patent patterns of anemia (Poovassery et al., 2009; Sarr et al., 2012).
Considering the discussion above, it is clear that mortality during pregnancy depends on a wide range of factors that ultimately will affect host survival. Most of them are commonly recapitulated in rodent experimental models in which experiments have contributed with important findings in this regard. However, one must carefully consider the often-fatal outcomes of murine infections induced by highly lethal parasites that are dissimilar to the infrequent lethality observed in human MiP.
In uterus Death and Abortion
In uterus death and abortion are rather infrequent outcomes of pregnancies complicated by malaria. However, there is a clear association between MiP development and stillbirth incidence, which is noted as being higher in women with perceivable placental parasitemia (Desai et al., 2007). In contrast, the association between abortion and MiP seems to be rarely discussed, with only scarce reports of this event occurring in low transmission areas, probably resulting from early trimester infections (Menendez, 1995; Desai et al., 2007). It is important to highlight that logistical constraints imposed by cultural and socioeconomic boundaries are the reason by which it is difficult to assess this particular pregnancy outcome. Interestingly, the incidence of abortion seems to be much more frequent in murine models than in humans. Accordingly, P. chabaudi AS infection of pregnant C57BL/6 mice revealed a rather frequent pattern of abortion and reduced fetal viability at mid-gestation (G10-12) when the parasite was inoculated immediately after conception. This event overlaps with the peripheral parasitemia peak and massive accumulation of parasites inside the placenta (Poovassery and Moore, 2006). As expected, the parasitemia peak and abortion were frequently observed in mice having increased production of cytokines in both peripheral blood (e.g., IL-1β and IL-10) and placenta (e.g., IFN-γ) (Poovassery and Moore, 2009). In a follow-up study, it was shown that fetal loss and reduced viability in pregnant C57BL/6 mice infected with P. chabaudi AS were markedly influenced by IFN-γ and TNF-α production (Poovassery et al., 2009) and increased coagulopathy and impaired fibrinolysis (Avery et al., 2012). In the same extent, abortion was shown to occur concomitantly with apoptosis of inflammatory cells and spongiotrophoblast in the junctional zone (between the uterus and the labyrinth), which has been discussed to occur in a way that is dependent on TNF-α signaling (Sarr et al., 2015). Altogether, these findings established a clear link between the immune response triggered against malaria and poor pregnancy outcomes. Moreover, models of abortion are also characterized by early infection with P. chabaudi, but stillbirth has also been observed in Swiss Albino (Vinayak et al., 1986; Pathak et al., 1990), BALB/c (Neres et al., 2008), and C57BL/6 (Rodrigues-Duarte et al., 2012) mice infected with P. berghei at mid-gestation. In these experimental models, reduced fetal viability without clear abortion observed at late gestation somewhat reflects stillbirth occurring in humans during the third gestational trimester (Desai et al., 2007).
Notably, it is important to highlight that translating these findings to human research may raise some serious controversies. Human stillbirth is often described as a dead conceptus that was expelled or removed from the womb 22 weeks after conception, being no longer considered an abortion (less than 22 weeks) (Lawn et al., 2016). In contrast, in the aforementioned murine models, there is no parallel measure at which fetal viability was assessed that considers gestational age. Vaginal secretions containing blood are normally taken as an indicative of early abortion, followed by the observation of necrotic structures (resorptions) that lack fetal or placental morphology (Poovassery and Moore, 2006; Neres et al., 2008). On the other hand, fetal viability is normally evaluated closer to term, after touching in uterus or delivered conceptus with pliers. Fetuses that fail to react are considered stillbirths (Neres et al., 2008). Therefore, definitions in these situations are often misleading, and conclusions should be made with extreme caution since abortion and stillbirth etiology may vary between rodent and human MiP.
Preterm Birth
Preterm birth, which encompasses every live birth that occurs before the 37th week of gestation (Goldenberg et al., 2009), is a more frequent consequence and is one of the leading causes of reduced birth weight associated with MiP (Menendez et al., 2000; Desai et al., 2007; Moore et al., 2017). Interestingly, the occurrence of spontaneous delivery in mice or rats in the context of MiP is either poorly addressed or considerably infrequent. One study reported the occurrence of preterm delivery of dead pups from pregnant BALB/c mice infected with P. berghei ANKA (Neres et al., 2008). However, this definition does not seem to fit the circumstance since preterm birth assumes that the progeny is born alive before term, which is unlikely to occur before G19 (reviewed elsewhere McCarthy et al., 2018). To the same extent, murine models have been questioned regarding their capacity to reproduce human preterm birth due to inaccurate measurements and non-standardized markers.
In this regard, evaluation of preterm birth in murine models of MiP is probably far from replicating human pathology. However, a better evaluation of this outcome may lead to improved disease models with more reliable translation capacities (McCarthy et al., 2018).
Progeny Outcomes and Development
Progeny outcomes and development will ultimately be severely affected as a result of the aforementioned clinical and obstetric manifestations during MiP. Often resulting from IUGR and/or preterm delivery, reduced birth weight contributes significantly to postnatal mortality and impaired child development across the malaria endemicity spectrum and is clearly more frequent in women during their first pregnancies (Nosten et al., 2004; Desai et al., 2007). It is unclear how MiP truly leads to growth restriction, yet evidences point to a multitude of factors such as angiogenic imbalance, endocrine dysregulation, deficiencies in transplacental nutrient transportation, severe inflammation and placental insufficiency (Umbers et al., 2011). During the 1980s, some studies reported the first observations of altered birth weight in mice suffering from MiP, which was found to be significantly diminished in pups from A/J, ICR (Oduola et al., 1982) and Swiss albino (Vinayak et al., 1986) litters born from mice infected with P. berghei NK65 and NICD, respectively. It seems that impaired progeny development is a rather well-conserved outcome of murine MiP since it was reported in BALB/c (Neres et al., 2008; Marinho et al., 2009; Megnekou et al., 2009; Silver et al., 2010) and C57BL/6 (Rodrigues-Duarte et al., 2012; Sharma et al., 2016) mice infected with a wide variety of parasite strains, suggesting the existence of conserved pathogenesis mechanisms (Rodrigues-Duarte et al., 2012). This pathologic outcome seems to be avoided with on-time administration of antimalarial drugs such as chloroquine and sulphadoxine-pyrimethamine, which were shown to abrogate systemic parasitemia, therefore improving offspring weight at delivery (Sharma and Shukla, 2014). Additionally, as it occurs in humans, progeny birth weight improved in mouse multigravidae. This trait was clearly shown to be gravidity-dependent, as pups belonging to the first litter were much smaller on average than those born from subsequent pregnancies when the corresponding dams were induced with MiP by recrudescent P. berghei ANKA (Marinho et al., 2009).
Further research conducted in the last decade revealed some hidden aspects of reduced birth weight etiology that would not be revealed without the wide range of genetically manipulated mice strains. Strikingly, it seems that proper fetal development is impaired upon the activation of specific components linked to innate immunity, such as complement system receptor (C5aR), Toll-like receptor 4 (TLR4), type I interferon receptor 1 (IFNAR1), and adaptor protein myeloid differentiation factor 88 (MyD88). BALB/c C5aR–/– (Conroy et al., 2013), C57BL/6 TLR4–/– (Barboza et al., 2017; Rodrigues-Duarte et al., 2018), C57BL/6 IFNAR–/– (Rodrigues-Duarte et al., 2018), and C57BL/6 MyD88–/– (Barboza et al., 2014, 2019) mice were shown to have litters with normal fetal weight, development and survival, even though being infected with P. berghei ANKA (in BALB/c) or P. berghei NK65 (in C57BL/6). These findings substantially advanced the field by strikingly implying the innate immune system on MiP-associated reduced birth weight pathogenesis, enabling future preclinical trials of anti-inflammatory drugs (e.g., the TLR4 antagonist IAXO) (Barboza et al., 2017) to be used concomitantly with antimalarial therapies to prevent MiP-associated poor pregnancy outcomes. However, progress in this field should also be done with extreme caution due to possible undesired side effects resulting from adjunctive therapies to treat severe malaria such as those observed in trials conducted with anti-TNF-α therapy to treat cerebral malaria and others (van Hensbroek et al., 1996; Varo et al., 2018).
Moreover, the postnatal scenario of human MiP might rarely include the appearance of congenital malaria, whose onset is tightly controlled by transplacental transmission of maternal antibodies to the fetus, resulting in isolated and scarce events often diagnosed as neonatal sepsis (Rai et al., 2015; Bhatia et al., 2016). Conceptus infection might occur due to blood exchanges at delivery or during pregnancy due to loss of villi integrity and syncytium rupture (Crocker et al., 2004; Robbins and Bakardjiev, 2012; Souza et al., 2013). By contrast, the phenomenon is thought to be even rarer in rodents. In related studies, the authors have clearly stated that no congenital malaria was observed, despite an increased fetal spleen weight, which might an indicative of fetal infection (Oduola et al., 1982; Vinayak et al., 1986). However, work by Adachi et al. (2000) addressed this question under the assumption that both mice and rats rarely transmit the parasite to their offspring. Accordingly, the authors detected parasites by nested PCR in a few pups born from pregnant BALB/c mice infected with P. berghei. These findings support the rareness of the event due to the lack of a uniform presence of parasites, even in pups within the same litter. The hemotrichorial layer in the murine placenta presents a much thicker barrier against transplacental passage of parasites than the human hemomonochorial placenta (Crocker et al., 2004), which might explain the reduced incidence of murine congenital malaria. Nevertheless, discrepancies in existing reports contraindicate the usage of murine models in this regard, identifying them as unsuitable for studying this rare disease outcome.
In conclusion, one may face challenges when translating pregnancy outcome findings obtained in murine models to human pathology. Nevertheless, significant achievements have been made in recent years, despite the considerable diversity of experimental settings and non-standardized methodologies. Improving them will certainly lead to enriched results and more accurate and meaningful conclusions taken from murine models of MiP.
Understanding Placental Pathology Using Murine Models of MiP
Most of the aforementioned outcomes occurring in pregnancies complicated by malaria are strongly associated with the dysregulation of placental homeostasis due to a significant accumulation of parasite-infected erythrocytes inside this organ, which overlaps with the onset of PM (Sharma and Shukla, 2017). Accordingly, several cytological and histological abnormalities are easily observed in infected placentas in addition to parasite accumulation, such as the malarial pigment hemozoin, immune cells, syncytial knots, fibrin deposition, necrosis and placental barrier thickening (Walter et al., 1982; Ismail et al., 2000; Souza et al., 2013). Although despite being PM hallmarks, not all of these histopathologic features are accurately shown by murine models of MiP (schematically represented in Figure 3).
Parasitized Erythrocytes
Parasitized erythrocytes tend to selectively accumulate in the placenta (Figures 1C,D), achieving greater parasitemia levels than those observed in the peripheral blood of pregnant infected women (Beeson et al., 2002; Muthusamy et al., 2004). It is unquestionable that murine parasites also accumulate inside the placenta (Figure 2D) since a large number of studies of placental histopathology noted this finding for a wide range of strains (Table 1). Notably, Poovassery and Moore (2006) have demonstrated that P. chabaudi AS parasites also accumulate preferentially inside the placenta of C57BL/6 mice, leading to greater placental parasitemia than that observed in peripheral blood. Interestingly, these murine parasite populations were shown to be mainly constituted by mature forms with an almost null percentage of early ring-stage parasites (Megnekou et al., 2009), which is in line with observations made during P. falciparum infections (Beeson et al., 2002). Similarly, intravital microscopy studies performed in placentas from pregnant mice infected either with P. berghei or P. chabaudi also suggested that those that accumulate are indeed the mature forms of the parasite (Lima et al., 2014), which preferably adhere to the trophoblast in areas of low blood flow inside the maternal blood sinusoids (de Moraes et al., 2013). As observed for P. falciparum regarding its preferential adhesion to CSA and controversial binding to hyaluronic acid (HA) (Beeson and Brown, 2004; Muthusamy et al., 2007), the adhesion of P. berghei was also shown to be dependent on placental CSA and HA as demonstrated by adhesion assays of mice IEs to placental sections treated with chondroitinase or hyaluronidase (Neres et al., 2008; Marinho et al., 2009). These findings once again support similar pathogenesis mechanisms between human and murine PM despite the lack of known PfEMP1 homologs (Hviid et al., 2010).
The Malarial Pigment Hemozoin
The malarial pigment hemozoin, a byproduct of hemoglobin catabolism performed by Plasmodium spp. to detoxify free heme (Olivier et al., 2014), is frequently observed in placentas from infected pregnant women (Figures 1E,F) and is often used as an indicator of PM, even in the absence of detectable parasites (Bulmer et al., 1993; Ismail et al., 2000). Similarly, placental infection by murine parasites also leads to hemozoin deposition (Figure 2F). Oduola and coworkers first observed this phenomenon in histologic sections of placentas from different murine backgrounds infected with P. berghei NK65. Shortly thereafter, the pigment was exclusively observed in maternal blood sinusoids, whose concentrations increased with augmented parasite loads. Accordingly, hemozoin-containing monocytes were also frequently observed (Oduola et al., 1982, 1986). In addition, hemozoin was also detected in trophoblast giant cells, suggesting an active phagocytic process (Poovassery and Moore, 2009). The pigment is frequently detected under polarized light microscopy (Neres et al., 2008; Megnekou et al., 2009) and is used to indicate past-chronic PM in humans according to the diagnostic criteria of Bulmer et al. (1993). To our knowledge, this event was rarely observed in murine models (Oduola et al., 1986). The fact that hemozoin was rarely observed alone in infected placentas suggests that the experimental settings from current models fail to reproduce past-chronic infections and are only able to reproduce acute PM.
Immune Cell Infiltrate
Immune cell infiltrate, which occurs as a response to parasite/hemozoin accumulation inside the placenta (Figure 1D), is one of the key hallmarks of the disease and is often associated with poor pregnancy outcomes (Menendez et al., 2000; Rogerson et al., 2003; Umbers et al., 2011). Monocytes/macrophages are the most abundant constituents of these inflammatory infiltrates, and recruitment is widely correlated with placental production of MIP-1α, MCP-1, I-309, and IL-8 chemokines (Abrams et al., 2003). Not surprisingly, the same event was observed in placentas from mice (Figure 2E) and rats infected with P. berghei, especially in those containing detectable placental parasites (Oduola et al., 1982, 1986; Tegoshi et al., 1992). Notably, the infiltrate, which was mainly composed of monocytes (CD11b+ve cells detected by cytochemistry) and macrophages (CD11b+ve cells detected by cytochemistry and Cd68- and Mgl2-expressing cells identified by qPCR), was linked to the production of some attractant chemokines, such as MIP-1α and MCP-1 (Neres et al., 2008; Marinho et al., 2009; Sarr et al., 2015; Barboza et al., 2017). However, the event is far from reflecting chronic intervillositis observed in humans (Ordi et al., 1998), probably due to the shorter gestational period in rodents. Additionally, some authors have commented on the scarcity of this event, especially in placentas from C57BL/6 mice infected with P. chabaudi, which tend to have fewer accumulated monocytes/macrophages due to reduced placental parasite burden (Poovassery and Moore, 2006; Poovassery et al., 2009). Early reports on different leukocyte populations in infected murine placentas noted the existence of mononuclear (Tegoshi et al., 1992) and polymorphonuclear (Oduola et al., 1986) cells. Molecular biology methods were later used to dissect these cell types, dividing them into dendritic cells (Mgl2), neutrophils (Ncf2), NK cells (Klrd1), T (Cd3e), and B (Cd22) lymphocytes (gene expression quantification by qPCR) (Marinho et al., 2009; Sarr et al., 2015; Barboza et al., 2017). Remarkably, this is in line with observations performed in human PM regarding the placental accumulation of NK cells, T lymphocytes and other non-specified polymorphonuclear cells (Ordi et al., 2001; Rogerson et al., 2007; Othoro et al., 2008). Nevertheless, despite the clear accumulation of immune cells in murine placentas, its association with poor pregnancy outcomes remains to be elucidated in experimental models that oppose current knowledge of human pathology (Rogerson et al., 2003; Umbers et al., 2011).
Placental Fibrinoid Necrosis
Placental fibrinoid necrosis normally occurs as a consequence of extensive placental tissue damage caused during Plasmodium spp. infection (Figure 1B). In fact, fibrin deposition is initiated to promote placental tissue repair but soon becomes cytotoxic, leading to necrosis (Walter et al., 1982; Ismail et al., 2000) and poor pregnancy outcomes such as premature delivery and reduced birth weight (Menendez et al., 2000; Avery et al., 2012). Likewise, pioneering studies from the 1980s revealed the presence of fibrinoid necrosis in placental sections from mice and rats infected with P. berghei, although without clear conclusions on its consequences (Oduola et al., 1986; Tegoshi et al., 1992). Later, fibrinoid necrosis was reported in placentas from P. berghei-infected BALB/c mice (Figure 2B), which delivered litters with a patently reduced birth weight phenotype (Neres et al., 2008), and fibrin thrombi in placentas from C57BL/6 mice infected with P. chabaudi that experienced spontaneous abortion (Poovassery et al., 2009). Discussion was taken to the point in which fibrin deposition in maternal blood sinusoids would significantly impair placental capability to perform physiological tasks such as respiration and nutrient exchanges, probably due to clotting, blood arrest, necrosis and trophoblast death. In a subsequent study, Avery et al. (2012) showed by western blot that fibrin deposits were increased in placentas from C57BL/6 mice infected with P. chabaudi, which occurred in parallel with an upregulation of coagulation-associated genes. These findings established an important association between impaired fibrinolysis and coagulation and the poor pregnancy outcomes of MiP.
Labyrinth Disarrangement
Labyrinth disarrangement will ultimately reflect murine placental dysfunction, which is characterized by particular histological alterations that have considerable differences from human PM, mostly due to the existence of a widely different villi structure (Figures 1A,B vs. Figures 2A–D). Of note, two features of human PM that have no counterparts in infected murine placentas are syncytiotrophoblast rupture (previously discussed in the context of congenital malaria) and syncytial knots (Ismail et al., 2000; Souza et al., 2013). These protrusions of syncytial nuclear aggregates, which have been associated with hypoxia and oxidative stress in human placentas (Heazell et al., 2007), were discussed as having no similar structure in murine placentas that could be detected under light or electron microscopy (Tegoshi et al., 1992). Syncytial knots, which are considered an accumulation of degrading nuclei, was once erroneously described as a phenomenon of trophoblast hyperplasia [discussed elsewhere (Heazell et al., 2007)]. To our knowledge, the latter was never clearly discussed in the context of human PM. Accordingly, there are unclear reports of trophoblast hyperplasia occurring in the placentas of mice (Oduola et al., 1986; Vinayak et al., 1986; Pathak et al., 1990; Neres et al., 2008) and rats (Oduola et al., 1986; Tegoshi et al., 1992) infected with P. berghei. Nevertheless, evidence of this event includes unclear microscopy images that fail to address the apparent enlargement/swelling of tissue that occurs due to cell proliferation. However, there is a striking thickening of the trophoblast basal membrane that partially overlaps with the concept of tissue swelling. In human PM, this frequent phenomenon can be qualitatively analyzed (Ismail et al., 2000) or more accurately quantified as the distance that separates fetal capillaries from villi outer membrane (Souza et al., 2013). Regardless of the methodology used, this parameter was found to be significantly thicker during human PM and, being discussed as strongly influencing transplacental transport of vital compounds. Similarly, this was qualitatively analyzed and reported in mouse and rat placentas infected with P. berghei, which was hypothesized to be a consequence of the fibrotic process resulting from massive tissue repair (Oduola et al., 1986; Tegoshi et al., 1992). Later, some other works have developed methods to indirectly quantify trophoblast thickening, taking advantage of the sinusoidal nature of mouse placentas. Accordingly, maternal blood areas were quantified, and the reduction of vascular spaces in placentas from BALB/c mice infected with P. berghei ANKA was considered a proxy for basal membrane thickening (Neres et al., 2008). This supports the conclusion that reduced maternal blood spaces due to trophoblast membrane thickening and maternal sinusoidal remodeling (de Moraes et al., 2013) would ultimately lead to placental insufficiency and impaired transplacental transport of nutrients [discussed elsewhere (Neres et al., 2008; de Moraes et al., 2013)]. The same methodology was further used to determine that distinct parasites inflict different magnitudes of circulatory impairment and membrane thickening in placentas from C57BL/6 mice (Rodrigues-Duarte et al., 2012). The etiology of the event was further addressed in P. berghei NK65-infected C57BL/6 TLR4–/– and MyD88–/– KO mice, which had blood sinusoidal areas similar to those observed in non-infected pregnant mice (Barboza et al., 2014, 2017). These findings established a logical link between host innate immunity and placental pathology, once again supporting the notion that outcomes of MiP mostly result from damage and homeostatic dysregulation inflicted mostly by factors of an immunologic nature.
Conclusion
Clearly, the development of murine models that recapitulate traits from human MiP has definitively contributed to the current understanding of this disease. However, there are still few reports that truly reveal some of the pathogenesis mechanisms of MiP. Only in the last decade have some studies clearly unraveled some hidden molecular mechanisms of MiP, such as innate immunity activation and its contributions to poor pregnancy outcomes (Poovassery et al., 2009; Conroy et al., 2013; Barboza et al., 2014, 2017, 2019; Rodrigues-Duarte et al., 2018). Indeed, the advent of genetic engineering and the capacity to generate a wide range of knockout mice were definite turning points from which we are still benefiting. Until this point, most studies have tried to establish proper experimental settings that would ultimately validate murine models as suitable for studying MiP. First, striking similarities are observed regarding evolutionary and developmental traits between murine and human placentas, from which one might conclude that physiologically, both would behave in a particularly similar way (Georgiades et al., 2002; Wildman et al., 2006). Additionally, murine parasites exhibit a group of characteristics that support the conclusion that murine pathology would somewhat resemble human MiP, despite the well-known differences between rodent Plasmodium species and P. falciparum biology (Lamb et al., 2006; Hviid et al., 2010). Nevertheless, one might consider the patent limitations of conclusions regarding disease outcomes, which can later limit the translational capacities of observed results. As such, refinement of experimental design and standardization of methodology is necessary for the improvement of such models (BOX 1). Resolving these gaps will certainly enrich research in the field, possibly reaffirming the usage of murine models to address more specific and complex questions implicit in drug preclinical trials and vaccine development (Doritchamou et al., 2017). Research in the field has indeed overcome several milestones due to the usage of rodent models with much progress that is still to come.
Box 1. Suggestions to improve future murine models of MiP.
Evolution has grouped murine animals and humans in similar phylogenetic clades according to some striking similarities. However, it has also separated them especially from an anatomically perspective. Some differences cannot be surpassed; yet, our understanding of some diseases and complex biological processes can be improved with the refinement of experimental design and standardization of analysis methods when using animal models such as experimental murine models of MiP. As such, our understanding of MiP could be improved by addressing some of the following points:
• Understanding the adhesion mechanism of murine parasite strains.
• Identification of VAR2CSA functional homologs in murine parasites.
• Standardization of protocols using specific species of murine parasites to differently address specific aspects of uncomplicated or severe MiP (e.g., usage of less or more virulent parasite strains, tropism for reticulocytes or mature erythrocytes, preferential tissue for accumulation).
• Standardized definitions and accurate measures for abortion, preterm delivery, stillbirth and placental malaria in the context of murine MiP.
• Investigating the possibility of congenital malaria in murine models of MiP.
Author Contributions
AB drafted the manuscript, compiled information from the literature, and designed the figures and tables. MP drafted the manuscript and gathered information from the literature. SE supervised and reviewed the manuscript. CM supervised and reviewed the manuscript and designed the figures and tables.
Funding
This work was primarily funded by the São Paulo Research Foundation – FAPESP (Grant Nos. 2018/20468-0 to CM and 2017/05782-8 to SE). AB and MP were supported by fellowships from the FAPESP (2017/03939-7 and 2012/10081-5, respectively).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Abrams, E. T., Brown, H., Chensue, S. W., Turner, G. D. H., Molyneux, M. E., Meshnick, S. R., et al. (2003). Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated β chemokine expression. J. Immunol. 170, 2759–2764. doi: 10.4049/jimmunol.170.5.2759
Adachi, M., Yuda, M., Ando, K., Sakurai, M., and Chinzei, Y. (2000). Scant parasitemia in BALB/c mice with congenital malaria infection. J. Parasitol. 86, 1030–1034. doi: 10.1645/0022-3395(2000)086
Al Hammadi, A., Mitchell, M., Abraham, G. M., and Wang, J. P. (2017). Recrudescence of Plasmodium falciparum in a primigravida after nearly 3 years of latency. Am. J. Trop. Med. Hyg. 96, 642–644. doi: 10.4269/ajtmh.16-0803
Avery, J. W., Smith, G. M., Owino, S. O., Sarr, D., Nagy, T., Mwalimu, S., et al. (2012). Maternal malaria induces a procoagulant and antifibrinolytic state that is embryotoxic but responsive to anticoagulant therapy. PLoS One 7:e31090. doi: 10.1371/journal.pone.0031090
Barboza, R., Hasenkamp, L., Barateiro, A., Murillo, O., Peixoto, E. P. M., Lima, F. A., et al. (2019). Fetal-derived MyD88 signaling contributes to poor pregnancy outcomes during gestational malaria. Front. Microbiol. 10:68. doi: 10.3389/fmicb.2019.00068
Barboza, R., Lima, F. A., Reis, A. S., Murillo, O. J., Peixoto, E. P. M., Bandeira, C. L., et al. (2017). TLR4-mediated placental pathology and pregnancy outcome in experimental malaria. Sci. Rep. 7, 1–12. doi: 10.1038/s41598-017-08299-x
Barboza, R., Reis, A. S., Silva, L. G., Da Hasenkamp, L., Pereira, K. R. B., Câmara, N. O. S., et al. (2014). MyD88 signaling is directly involved in the development of murine placental malaria. Infect. Immun. 82, 830–838. doi: 10.1128/IAI.01288-1213
Beeson, J. G., Amin, N., Kanjala, M., and Rogerson, S. J. (2002). Selective accumulation of mature asexual stages of plasmodium falciparum -infected erythrocytes in the placenta. Infect. Immun. 70, 5412–5415. doi: 10.1128/IAI.70.10.5412
Beeson, J. G., and Brown, G. V. (2004). Plasmodium falciparum–infected erythrocytes demonstrate dual specificity for adhesion to hyaluronic acid and chondroitin sulfate a and have distinct adhesive properties. J. Infect. Dis. 189, 169–179. doi: 10.1086/380975
Berrevoets, M. A. H., Sprong, T., Meis, J. F., and Dofferhoff, A. S. M. (2013). Plasmodium falciparum malaria recrudescence occurring 2.5 years after leaving an endemic country. Neth. J. Med. 71, 426–428.
Bhatia, R., Rajwaniya, D., and Agrawal, P. (2016). Congenital malaria due to plasmodium vivax infection in a neonate. Case Rep. Pediatr. 2016, 1–2. doi: 10.1155/2016/1929046
Brabin, B. J., Hakimi, M., and Pelletier, D. (2001). An analysis of anemia and pregnancy-related maternal mortality. J. Nutr. 131, 604S–615S. doi: 10.1093/jn/131.2.697S
Bulmer, J. N., Rasheed, F. N., Francis, N., Morrison, L., and Greenwood, B. M. (1993). Placental malaria.1. Pathological Classification. Histopathology 22, 211–218.
Burton, G. J., Hempstock, J., and Jauniaux, E. (2001). Nutrition of the human fetus during the first trimester - a review. Placenta 22, 70–76. doi: 10.1053/plac.2001.0639
Burton, G. J., Watson, A. L., Hempstock, J., Skepper, J. N., and Jauniaux, E. (2002). Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 87, 2954–2959. doi: 10.1210/jcem.87.6.8563
Cattamanchi, A., Kyabayinze, D., Hubbard, A., Rosenthal, P. J., and Dorsey, G. (2003). Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of MSP-1. MSP-2, and GLURP. Am. J. Trop. Med. Hyg. 68, 133–139. doi: 10.1186/1475-2875-5-127
Conroy, A. L., Silver, K. L., Zhong, K., Rennie, M., Ward, P., Sarma, J. V., et al. (2013). Complement activation and the resulting placental vascular insufficiency drives fetal growth restriction associated with placental malaria. Cell Host Microbe 13, 215–226. doi: 10.1016/j.chom.2013.01.010
Crocker, I. P., Walraven, G., Tanner, O. M., Baker, P. N., Myers, J. E., and Bulmer, J. N. (2004). Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta. Placenta 25, 273–282. doi: 10.1016/j.placenta.2003.09.010
de Moraes, L. V., Tadokoro, C. E., Gómez-Conde, I., Olivieri, D. N., and Penha-Gonçalves, C. (2013). Intravital placenta imaging reveals microcirculatory dynamics impact on sequestration and phagocytosis of plasmodium-infected erythrocytes. PLoS Pathog. 9:e1003154. doi: 10.1371/journal.ppat.1003154
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., and Ter Kuile, F. O. (2010). Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 7:e1000221. doi: 10.1371/journal.pmed.1000221
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., et al. (2007). Epidemiology and burden of malaria in pregnancy. Lancet Infect. Dis. 7, 93–104. doi: 10.1016/S1473-3099(07)70021-X
Desowitz, R. S., Shida, K. K., Pang, L., and Buchbinder, G. (1989). Characterization of a model of malaria in the pregnant host: plasmodium berghei in the white rat. Am. J. Trop. Med. Hyg. 41, 630–634. doi: 10.4269/ajtmh.1989.41.630
Doritchamou, J., Teo, A., Fried, M., and Duffy, P. E. (2017). Malaria in pregnancy: the relevance of animal models for vaccine development. Lab Anim. 46, 388–398. doi: 10.1038/laban.1349
Duffy, P. E., and Fried, M. (2001). “Malaria in pregnancy,” in Deadly Parasite, Susceptible Host, 1st Edn, eds P. E. Duffy and M. Fried (London: Taylor & Francis).
Franke-Fayard, B., Fonager, J., Braks, A., Khan, S. M., and Janse, C. J. (2010). Sequestration and tissue accumulation of human malaria parasites: can we learn anything from rodent models of malaria? PLoS Pathog. 6:e1001032. doi: 10.1371/journal.ppat.1001032
Fried, M., Domingo, G. J., Gowda, C. D., Mutabingwa, T. K., and Duffy, P. E. (2006). Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta. Exp. Parasitol. 113, 36–42. doi: 10.1016/j.exppara.2005.12.003
Georgiades, P., Fergyson-Smith, A. C., and Burton, G. J. (2002). Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23, 3–19. doi: 10.1053/plac.2001.0738
Giobbia, M., Tonon, E., Zanatta, A., Cesaris, L., Vaglia, A., and Bisoffi, Z. (2005). Late recrudescence of Plasmodium falciparum malaria in a pregnant woman: a case report. Int. J. Infect. Dis. 9, 234–235. doi: 10.1016/j.ijid.2004.08.002
Goldenberg, R., Culhane, J., and Iams, J. (2009). Preterm birth 1: epidemiology and causes of preterm birth. Obstet. Anesth. 371, 75–84. doi: 10.1111/j.1440-1754.2012.02536.x
Hall, N., Marianna, K., Raine, J. D., Carlton, J. M., Kooij, T. W. A., Berriman, M., et al. (2005). A comprehensive survey of the plasmodium life cycle by genomic. transcriptomic, and proteomic analyses. Science 307, 82–86. doi: 10.1126/science.1103717
Heazell, A. E. P., Moll, S. J., Jones, C. J. P., Baker, P. N., and Crocker, I. P. (2007). Formation of syncytial knots is increased by hyperoxia. hypoxia and reactive oxygen species. Placenta 28, S33–S40. doi: 10.1016/j.placenta.2006.10.007
Hioki, A., Hioki, Y., and Ohtomo, H. (1990). Influence of pregnancy on the course of malaria in mice infected with plasmodium berghei. J. Protozool. 37, 163–167. doi: 10.1111/j.1550-7408.1990.tb01121.x
Hviid, L., Marinho, C. R. F., Staalsoe, T., and Penha-Gonçalves, C. (2010). Of mice and women: rodent models of placental malaria. Trends Parasitol. 26, 412–419. doi: 10.1016/j.pt.2010.04.010
Ismail, M. R., Ordi, J., Menendez, C., Ventura, P. J., Aponte, J. J., Kahigwa, E., et al. (2000). Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum. Pathol. 31, 85–93. doi: 10.1016/S0046-8177(00)80203-80208
Janssen, C. S., Phillips, R. S., Turner, M. R., and Barret, M. P. (2004). Plasmodium interspersed repeats: the major multigene superfamily of malaria parasites. Nucleic Acids Res. 32, 5712–5720. doi: 10.1093/nar/gkh907
Justice, M. J., and Dhillon, P. (2016). Using the mouse to model human disease: increasing validity and reproducibility. Dis. Model. Mech. 9, 101–103. doi: 10.1242/dmm.024547
Kanellopoulos-Langevin, C., Caucheteux, S. M., Verbeke, P., and Ojcius, D. M. (2003). Tolerance of the fetus by the maternal immune system: role of inflammatory mediators at the feto-maternal interface. Reprod. Biol. Endocrinol. 1, 1–6. doi: 10.1186/1477-7827-1-121
Kraemer, S. M., and Smith, J. D. (2006). A family affair: var genes, PfEMP1 binding, and malaria disease. Curr. Opin. Microbiol. 9, 374–380. doi: 10.1016/j.mib.2006.06.006
Lager, S., and Powell, T. L. (2012). Regulation of nutrient transport across the placenta. J. Pregnancy 2012, 1–14. doi: 10.1155/2012/179827
Lamb, T. J., Brown, D. E., Potocnik, A. J., and Langhorne, J. (2006). Insights into the immunopathogenesis of malaria using mouse models. Expert Rev. Mol. Med. 8, 1–22. doi: 10.1017/S1462399406010581
Laochan, N., Zaloumis, S., Imwong, M., Lek-Uthai, U., Brockman, A., Sriprawat, K., et al. (2015). Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort. Malar. J. 14:221. doi: 10.1186/s12936-015-0745-749
Lawn, J. E., Blencowe, H., Waiswa, P., Amouzou, A., Mathers, C., Hogan, D., et al. (2016). Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet 387, 587–603. doi: 10.1016/S0140-6736(15)00837-835
Lima, F. A., Gómez-Conde, I., Videira, P. A., Marinho, C. R. F., Olivieri, D. N., and Tadokoro, C. E. (2014). Intravital microscopy technique to study parasite dynamics in the labyrinth layer of the mouse placenta. Parasitol. Int. 63, 254–259. doi: 10.1016/j.parint.2013.06.012
Lucchi, N. W., Sarr, D., Owino, S. O., Mwalimu, S. M., Peterson, D. S., and Moore, J. M. (2011). Natural hemozoin stimulates syncytiotrophoblast to secrete chemokines and recruit peripheral blood mononuclear cells. Placenta 32, 579–585. doi: 10.1016/j.placenta.2011.05.003
Luxemburger, C., Ricci, F., Nosten, F., Raimond, D., Bathet, S., and White, N. J. (1997). The epidemiology of severe malaria in an area of low transmission in Thailand. Trans. R. Soc. Trop. Med. Hyg. 91, 256–262. doi: 10.1016/S0035-9203(97)90066-3
Malvy, D., Torrentino-Madamet, M., L’Ollivier, C., Receveur, M. C., Jeddi, F., Delhaes, L., et al. (2018). Plasmodium falciparum recrudescence two years after treatment of an uncomplicated infection without return to an area where malaria is endemic. Antimicrob. Agents Chemother. 62, 1–5. doi: 10.1128/AAC.01892-1817
Marinho, C. R. F., Neres, R., Epiphanio, S., Gonçalves, L. A., Catarino, M. B., and Penha-Gonçalves, C. (2009). Recrudescent Plasmodium berghei from pregnant mice displays enhanced binding to the placenta and induces protection in multigravida. PLoS One 4:e5630. doi: 10.1371/journal.pone.0005630
Mayor, A., Serra-Casas, E., Bardají, A., Sanz, S., Puyol, L., Cisteró, P., et al. (2009). Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women. Malar. J. 8, 1–10. doi: 10.1186/1475-2875-8-9
McCarthy, R., Martin-Fairey, C., Sojka, D. K., Herzog, E. D., Jungheim, E. S., Stout, M. J., et al. (2018). Mouse models of preterm birth: suggested assessment and reporting guidelines†. Biol. Reprod. 99, 922–937. doi: 10.1093/biolre/ioy109
Megnekou, R., Hviid, L., and Staalsoe, T. (2009). Variant-specific immunity to Plasmodium berghei in pregnant mice. Infect. Immun. 77, 1827–1834. doi: 10.1128/IAI.01321-1328
Menendez, C. (1995). Malaria during pregnancy: a priority area of malaria research and control. Parasitol 11, 178–183. doi: 10.1016/0169-4758(95)80151-0
Menendez, C., Ordi, J., Ismail, M. R., Ventura, P. J., Aponte, J. J., Kahigwa, E., et al. (2000). The impact of placental malaria on gestational age and birth weight. J. Infect. Dis. 181, 1740–1745. doi: 10.1086/315449
Menéndez, C., Romagosa, C., Ismail, M. R., Carrilho, C., Saute, F., Osman, N., et al. (2008). An autopsy study of maternal mortality in Mozambique: the contribution of infectious diseases. PLoS Med. 5:e44. doi: 10.1371/journal.pmed.0050044
Moore, K. A., Simpson, J. A., Wiladphaingern, J., Min, A. M., Pimanpanarak, M., Paw, M. K., et al. (2017). Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission. BMC Med. 15:117. doi: 10.1186/s12916-017-0877-6
Moormann, A. M., Sullivan, A. D., Rochford, R. A., Chensue, S. W., Bock, P. J., Nyirenda, T., et al. (1999). Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J. Infect. Dis. 180, 1987–1993. doi: 10.1086/315135
Murray, S. A., Morgan, J. L., Kane, C., Sharma, Y., Heffner, C. S., Lake, J., et al. (2010). Mouse gestation length is genetically determined. PLoS One 5:e12418. doi: 10.1371/journal.pone.0012418
Muthusamy, A., Achur, R. N., Bhavanandan, V. P., Fouda, G. G., Taylor, D. W., and Gowda, D. C. (2004). Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor. Am. J. Pathol. 164, 2013–2025. doi: 10.1016/S0002-9440(10)63761-63763
Muthusamy, A., Achur, R. N., Valiyaveettil, M., Botti, J. J., Taylor, D. W., Leke, R. F., et al. (2007). Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression. Am. J. Pathol. 170, 1989–2000. doi: 10.2353/ajpath.2007.061238
Neres, R., Marinho, C. R. F., Gonçalves, L. A., Catarino, M. B., and Penha-Gonçalves, C. (2008). Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women. PLoS One 3:e1608. doi: 10.1371/journal.pone.0001608
Nosten, F., Rogerson, S. J., Beeson, J. G., McGready, R., Mutabingwa, T. K., and Brabin, B. (2004). Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol. 20, 425–432. doi: 10.1016/j.pt.2004.06.007
Oduola, A. M. J., Holbrook, T. W., Galbraith, R. M., Bank, H., and Spicer, S. S. (1982). Effects of malaria (Plasmodium berghei) on the maternal-fetal relationship in mice. J. Protozool. 29, 77–81. doi: 10.1111/j.1550-7408.1982.tb02883.x
Oduola, A. M. J., Phillips, J. H., Spicer, S. S., and Galbraith, R. M. (1986). Plasmodium berghei - histology. immunocytochemistry, and ultrastructure of the placenta in rodent malaria. Exp. Parasitol. 62, 181–193. doi: 10.1016/0014-4894(86)90022-6
Olivier, M., Van Den Ham, K., Shio, M. T., Kassa, F. A., and Fougeray, S. (2014). Malarial pigment hemozoin and the innate inflammatory response. Front. Immunol. 5:25. doi: 10.3389/fimmu.2014.00025
Ordi, J., Ismail, M. R., Ventura, P. J., Kahigwa, E., Hirt, R., Cardesa, A., et al. (1998). Massive chronic intervillositis of the placenta associated with malaria infection. Am. J. Surg. Pathol. 22, 1006–1011. doi: 10.1097/00000478-199808000-00011
Ordi, J., Menendez, C., Ismail, M. R., Ventura, P. J., Palacín, A., Kahigwa, E., et al. (2001). Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells. J. Infect. Dis. 183, 1100–1107. doi: 10.1086/319295
Othoro, C., Moore, J. M., Wannemuehler, K. A., Moses, S., Lal, A., Otieno, J., et al. (2008). Elevated gamma interferon-producing NK cells, CD45RO memory-like T cells, and CD4 T cells are associated with protection against malaria infection in pregnancy. Infect. Immun. 76, 1678–1685. doi: 10.1128/IAI.01420-1427
Parekh, F. K., Davison, B. B., Gamboa, D., Hernandez, J., and Branch, O. L. H. (2010). Placental histopathologic changes associated with subclinical malaria infection and its impact on the fetal environment. Am. J. Trop. Med. Hyg. 83, 973–980. doi: 10.4269/ajtmh.2010.09-0445
Pathak, G., Asnani, P. J., and Vinayak, V. K. (1990). Effect of prior eradication of Plasmodium berghei infection on the foetal development and parasitaemic levels under the stress of pregnancy. J. Hyg. Epidemiol. Microbiol. Immunol. 34, 139–146.
Pavia, C. S., and Niederbuhl, C. J. (1991). Immunization and protection against malaria during murine pregnancy. Am. J. Trop. Med. Hyg. 44, 176–182. doi: 10.4269/ajtmh.1991.44.176
Poovassery, J., and Moore, J. M. (2006). Murine malaria infection induces fetal loss associated with accumulation of Plasmodium chabaudi AS-infected erythrocytes in the placenta. Infect. Immun. 74, 2839–2848. doi: 10.1128/IAI.74.5.2839-2848.2006
Poovassery, J., and Moore, J. M. (2009). Association of malaria-induced murine pregnancy failure with robust peripheral and placental cytokine responses. Infect. Immun. 77, 4998–5006. doi: 10.1128/IAI.00617-619
Poovassery, J. S., Sarr, D., Smith, G., Nagy, T., and Moore, J. M. (2009). Malaria-induced murine pregnancy failure: distinct roles for IFN-γ and TNF. J. Immunol. 183, 5342–5349. doi: 10.4049/jimmunol.0901669
Rai, P., Majumdar, K., Sharma, S., Chauhan, R., and Chandra, J. (2015). Congenital malaria in a neonate: case report with a comprehensive review on differential diagnosis, treatment and prevention in Indian perspective. J. Parasit. Dis. 39, 345–348. doi: 10.1007/s12639-013-0342-341
Robbins, J. R., and Bakardjiev, A. I. (2012). Pathogens and the placental fortress. Curr. Opin. Microbiol. 15, 36–43. doi: 10.1016/j.mib.2011.11.006
Rodrigues-Duarte, L., De Moraes, L. V., Barboza, R., Marinho, C. R., Franke-Fayard, B., Janse, C. J., et al. (2012). Distinct placental malaria pathology caused by different Plasmodium berghei lines that fail to induce cerebral malaria in the C57BL/6 mouse. Malar. J. 11, 1–9. doi: 10.1186/1475-2875-11-231
Rodrigues-Duarte, L., Pandya, Y., Neres, R., and Penha-Gonçalves, C. (2018). Fetal and maternal innate immunity receptors have opposing effects in severity of experimental malaria in pregnancy: beneficial roles for fetal-derived TLR4 and IFNAR1. Infect. Immun. 86, IAI.708–IAI.717. doi: 10.1128/IAI.00708-717
Rogerson, S. J., Desai, M., Mayor, A., Sicuri, E., Taylor, S. M., and van Eijk, A. M. (2018). Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect. Dis. 18, e107–e118. doi: 10.1016/S1473-3099(18)30066-30065
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., and Taylor, D. W. (2007). Malaria in pregnancy: pathogenesis and immunity. Lancet Infect. Dis. 7, 105–117. doi: 10.1016/S1473-3099(07)70022-70021
Rogerson, S. J., Pollina, E., Getachew, A., Tadesse, E., Lema, V. M., and Molyneux, M. E. (2003). Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am. J. Trop. Med. Hyg. 68, 115–119. doi: 10.4269/ajtmh.2003.68.1.0680115
Rossant, J., and Cross, J. C. (2001). Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2, 538–548. doi: 10.1038/35080570
Rossant, J., and Tam, P. P. L. (2017). New insights into early human development: lessons for stem cell derivation and differentiation. Cell Stem Cell 20, 18–28. doi: 10.1016/j.stem.2016.12.004
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., et al. (2003). Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol. Microbiol. 49, 179–191. doi: 10.1046/j.1365-2958.2003.03570.x
Sarr, D., Bracken, T. C., Owino, S. O., Cooper, C. A., Smith, G. M., Nagy, T., et al. (2015). Differential roles of inflammation and apoptosis in initiation of mid-gestational abortion in malaria-infected C57BL/6 and A/J mice. Placenta 36, 738–749. doi: 10.1016/j.placenta.2015.04.007
Sarr, D., Smith, G. M., Poovassery, J. S., Nagy, T., and Moore, J. M. (2012). Plasmodium chabaudi AS induces pregnancy loss in association with systemic pro-inflammatory immune responses in A/J and C57BL/6 mice. Parasite Immunol. 34, 224–235. doi: 10.1111/j.1365-3024.2012.01355.x
Schofield, L., and Grau, G. E. (2005). Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5, 722–735. doi: 10.1038/nri1686
Sharma, A., Conteh, S., Langhorne, J., and Duffy, P. E. (2016). Heterologous infection of pregnant mice induces low birth weight and modifies offspring susceptibility to malaria. PLoS One 11:e0160120. doi: 10.1371/journal.pone.0160120
Sharma, L., and Shukla, G. (2014). Treatment of pregnant BALB/c mice with sulphadoxine pyrimethamine or chloroquine abrogates Plasmodium berghei induced placental pathology. Parasitol. Int. 63, 49–56. doi: 10.1016/j.parint.2013.08.016
Sharma, L., and Shukla, G. (2017). Placental malaria: a new insight into the pathophysiology. Front. Med. 4:117. doi: 10.3389/fmed.2017.00117
Shulman, C. E., Dorman, E. K., and Bulmer, J. N. (2002). Malaria as a cause of severe anaemia in pregnancy. Lancet 360:494. doi: 10.1016/s0140-6736(02)09662-9
Silver, K. L., Zhong, K., Leke, R. G. F., Taylor, D. W., and Kain, K. C. (2010). Dysregulation of angiopoietins is associated with placental malaria and low birth weight. PLoS One 5:e9481. doi: 10.1371/journal.pone.0009481
Souza, R. M., Ataíde, R., Dombrowski, J. G., Ippólito, V., Aitken, E. H., Valle, S. N., et al. (2013). Placental histopathological changes associated with plasmodium vivax infection during pregnancy. PLoS Negl. Trop. Dis. 7:e2071. doi: 10.1371/journal.pntd.0002071
Takao, K., and Miyakawa, T. (2015). Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci. 112, 1167–1172. doi: 10.1073/pnas.1401965111
Takata, K., Fujikura, K., and Shin, B.-C. (1997). Ultrastructure of the rodent placental labyrinth: a site of barrier and transport. J. Reprod. Dev. 43, 13–24. doi: 10.1262/jrd.43.13
Tegoshi, T., Desowitz, R. S., Pirl, K. G., Maeno, Y., and Aikawa, M. (1992). Placental pathology in plasmodium berghei-infected Rats. Am. J. Trop. Med. Hyg. 47, 643–651. doi: 10.4269/ajtmh.1992.47.643
Umbers, A. J., Aitken, E. H., and Rogerson, S. J. (2011). Malaria in pregnancy: small babies, big problem. Trends Parasitol. 27, 168–175. doi: 10.1016/j.pt.2011.01.007
van Hensbroek, M. B., Palmer, A., Onyiorah, E., Schneider, G., Jaffar, S., Dolan, G., et al. (1996). The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J. Infect. Dis. 174, 1091–1097. doi: 10.1093/infdis/174.5.1091
van Zon, A. A. J. C., and Eling, W. M. C. (1980). Pregnancy associated recrudescence in murine malaria (Plasmodium berghei). Tropenmed. Parasitol. 31, 402–408.
van Zon, A. A. J. C., Eling, W. M. C., and Hermsen, C. C. (1985). Pregnancy-induced recrudescences strengthen malarial immunity in mice infected with Plasmodium berghei. Parasitology 91, 9–17. doi: 10.1017/s003118200005647x
van Zon, A. A. J. C., Eling, W. M. C., Hermsen, C. C. R., and Koekkoek, A. A. G. M. (1982). Corticosterone regulation of the effector function of malarial immunity during pregnancy. Infect. Immun. 36, 484–491. doi: 10.1016/j.scitotenv.2015.10.076
Varo, R., Crowley, V. M., Sitoe, A., Madrid, L., Serghides, L., Kain, K. C., et al. (2018). Adjunctive therapy for severe malaria: a review and critical appraisal. Malar. J. 17, 1–18. doi: 10.1186/s12936-018-2195-2197
Vinayak, V. K., Pathak, G., Asnani, P. J., Jain, S., and Malik, A. K. (1986). Influence of malarial infection on the maternal-foetal relationship in pregnant mice. Aust. J. Exp. Biol. Med. Sci. 64, 223–227. doi: 10.1038/icb.1986.24
Walter, P. R., Garin, Y., and Blot, P. (1982). Placental pathologic changes in malaria: a histologic and ultrastructural study. Am. J. Pathol. 109, 330–342.
Wildman, D. E., Chen, C., Erez, O., Grossman, L. I., Goodman, M., and Romero, R. (2006). Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc. Natl. Acad. Sci. U.S.A. 103, 3203–3208. doi: 10.1073/pnas.0511344103
Keywords: murine models, Plasmodium spp., malaria, pregnancy, placental malaria
Citation: Barateiro A, Pereira MLM, Epiphanio S and Marinho CRF (2019) Contribution of Murine Models to the Study of Malaria During Pregnancy. Front. Microbiol. 10:1369. doi: 10.3389/fmicb.2019.01369
Received: 02 April 2019; Accepted: 31 May 2019;
Published: 19 June 2019.
Edited by:
Demba Sarr, University of Georgia, United StatesReviewed by:
Justin Yai Alamou Doritchamou, National Institutes of Health (NIH), United StatesAdrian John Frederick Luty, Institut de Recherche pour le Développement (IRD), France
Julie M. Moore, University of Florida, United States
Copyright © 2019 Barateiro, Pereira, Epiphanio and Marinho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Claudio R. F. Marinho, bWFyaW5ob0B1c3AuYnI=